Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen

Joe Abdo; Christopher S Wichman; Nicholas E Dietz; Pawel Ciborowski; John Fleegel; Sumeet K Mittal; Devendra K Agrawal

doi:10.3389/fonc.2019.00273

Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen

Front Oncol. 2019 Apr 12:9:273. doi: 10.3389/fonc.2019.00273. eCollection 2019.

Authors

Joe Abdo¹, Christopher S Wichman², Nicholas E Dietz^{1

3}, Pawel Ciborowski⁴, John Fleegel¹, Sumeet K Mittal^{1

5}, Devendra K Agrawal¹

Affiliations

¹ Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, United States.
² Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States.
³ Department of Pathology, CHI Health Creighton University Medical Center, College of Medicine, Omaha, NE, United States.
⁴ Department of Pharmacology, University of Nebraska Medical Center, Omaha, NE, United States.
⁵ Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Dignity Health, Phoenix, AZ, United States.

Abstract

[This corrects the article DOI: 10.3389/fonc.2018.00157.].

Keywords: SWATH analysis; chemoresistance markers; formalin-fixed paraffin-embedded tissue; mass spectrometry; molecular oncology; proliferation markers; proteomics.

Publication types

Published Erratum